Human mast cell cytokines

Clinical and Experimental Allergy

Volumn 26, Issue 1, 1996, Pages 13-19

  Bradding, P ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; MESSENGER RNA; PROTEOGLYCAN;

ALLERGY; HUMAN; MAST CELL; MOUSE; PRIORITY JOURNAL; RAT; REVIEW;

ANIMALS; CYTOKINES; HUMANS; MAST CELLS;

EID: 0030064965     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00051.x     Document Type: Review

References (56)

1. Church MK, Okayama Y, Bradding P. Functional mast cell heterogeneity. In: Asthma and Rhinitis. Holgate ST (ed). Boston: Blackwell Scientific Publications, Inc., 1994: 209-20.
2. Bradding P, Walls AF, Church MK. Mast cells and basophils: their role in initiating and maintaining inflammatory responses. In: Immunopharmacology of the Respiratory Tract - A Handbook of Immunopharmacology. Page CP (ed). London: Academic Press (in press).
3. Chung SW, Wong PMC, Shen-Ong G et al. Production of granulocyte-macrophage colony-stimulating factor by Abelson virus-induced tumorigenic mast cell lines. Blood 1986; 68:1074-81.
4. Brown MA, Pierce JH, Watson CJ et al. B cell stimulatory factor-1/interleukin 4 mRNA is expressed by normal and transformed mast cells. Cell 1987; 50:809-18.
5. t RI or to calcium ionophores. Nature 1989; 339:64-7.
6. Wodnar-Filipowicz A, Heusser CH, Moroni C. Production of the haemopoietic growth factors GM-CSF and interleukin 3 by mast cells in response to IgE receptor-mediated activation. Nature 1989; 339:150-2.
7. Burd PR, Rogers HW, Gordon JR et al. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989; 170:245-57.
8. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNFα/cachectin. Nature 1990; 346:274-6.
9. Leal-Berumen I, Conlon P, Marshall JS. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial liopolysaccharide. J Immunol 1994; 152:5468-76.
10. Zhang Y, Ramos BF, Jakschik BA. Neutrophil recruitment by tumour necrosis factor from mast cells in immune complex peritonitis. Science 1992; 258:1957-9.
11. Wershill BK, Mekori YA, Murakami T, Galli SJ. 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol 1987; 139:2605-14.
12. Wershill BK, Wang Z-S, Gordon JR, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with tumour necrosis factor-alpha. J Clin Invest 1991; 87:446-53.
13. t RI. A mechanism for the sustained action of mast cell-derived TNFα during IgE-dependent biological responses. J Exp Med 1991; 174:103-7.
14. Wershill BK, Murakami T, Galli SJ. Mast cell amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J Immunol 1988; 140:2356-60.
15. Matsuda H, Kawakita K, Kiso Y, Nakano T, Kitamura Y. Substance P induces granulocyte infiltration through degranulation of mast cells. J Immunol 1989; 142:927-31.
16. Tannenbaum S, Oertel H, Henderson W, Kaliner M. The biologic activity of mast cell granules. I. Elicitation of inflammatory responses in rat skin. J Immunol 1980; 125:325-35.
17. Klein LM, Lavker RM, Matis WL, Murphy GF. Degranulation of human mast cells induces an endothelial antigen central to leucocyte adhesion. Proc Natl Acad Sci USA 1989; 86:8972-6.
18. Walsh LJ, Trinchieri G, Waldorf HA, Whittaker D, Murphy GF. Human dermal mast cells contain and release tumour necrosis factor-α, which induces endothelial leucocyte adhesion molecule-1. Proc Natl Acad Sci USA 1991; 88:4220-4.
19. Ohkawara Y, Yamauchi K, Tanno Y et al. Human lung mast cells and pulmonary macrophages produce tumour necrosis factor α in sensitised lung tissue after IgE receptor triggering. Am J Respir Cell Mol Biol 1992; 7:385-92.
20. Bradding P, Feather IH, Howarth PH et al. Interleukin 4 is localised to and released by human mast cells. J Exp Med 1992; 176:1381-6.
21. Wilson SJ, Bradding P, Heusser CH, Holgate ST. The suhcellular localisation of interleukin 4 in the respiratory mucosa using immunoelectron microscopy. Clin Exp Allergy 1994; 24(abstr.):980.
22. Bradding P, Feather IH, Wilson S et al. Immunolocalisation of cytokines in the nasal mucosa of normal and perennial rhinitic subjects: The mast cell as a source of IL-4, IL-5 and IL-6 in human allergic mucosal inflammation. J Immunol 1993; 151:3853-65.
23. Bradding P, Roberts JA, Britten KM et al. Interleukins (IL)-4, -5, -6 and TNFα in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
24. Bradding P, Mediwake R, Feather IH et al. TNFα is localized to nasal mucosal mast cells and is released in acute allergic rhinitis. Clin Exp Allergy 1995; 25:406-15.
25. Bradding P, Feather IH, Wilson S, Holgate ST, Howarth PH. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med 1995; 151:1900-6.
26. Bradding P, Okayama Y, Howarth PH, Church MK, Holgate ST. Heterogeneity of human mast cells based on their cytokine content. J Immunol (in press).
27. Horsmanheimo L, Harvima IT, Jarvikallio A et al. Mast cells are one major source of interleukin 4 in atopic dermatitis. Br J Dermatol 1994; 131:348-53.
28. Möller A, Lippert U, Lessmann D et al. Human mast cells produce IL-8 J Immunol 1993; 154:3261-5.
29. t receptor cross-linkage and the presence of stem cell factor. J Immunol (in press).
30. Ying S, Durham SR, Barkans J et al. T cells are the principal source of interleukin 5 mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 1993; 9:356-60.
31. Ying S, Durham SR, Jacobson MR et al. T lymphocytes and mast cells express messenger RNA for interleukin 4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994; 82:200-6.
32. Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1 (interleukin 2 and interferon γ) cytokines in bronchoalveolar lavage fluid and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol 1995; 12:477-87.
33. Jaffe JS, Schulman ES. Activation of human lung mast cells induces early expression of IL-5 mRNA, but not IL-3, IL-4, and GM-CSF. J Immunol 1993; 150(abstr):147A.
34. Jaffe JS, Schulman ES, Wang Y. IgE-dependent secretion of IL-5 by lung fragments and human lung mast cells. J Allergy Clin Immunol 1994; 93(abstr):225.
35. Tepper RI, Levinson DA, Stranger BZ et al. IL-4 induces allergic-like inflammatory disease and alters T-cell development in transgenic mice. Cell 1990; 62:457-67.
36. Dent LA, Strath M, Mellor AL, Sanderson CJ. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990; 172:1425-31.
37. Akira S, Taga T, Kishimoto T. Interleukin 6 in biology and medicine. Adv Immunol 1993; 54:1-78.
38. Vassalli P. The pathophysiology of tumour necrosis factors. Annu Rev Immunol 1992; 10:411-52.
39. Yates DH, Barnes PJ, Thomas PS. Neutrophil influx and increased bronchial reactivity associated with inhaled tumour necrosis factor-α. Thorax 1993; 48(abstr):1080.
40. Dolovich J, Hargreave FE, Chalmers R et al. Late cutaneous allergic responses in isolated IgE-dependent reactions. J Allergy Clin Immunol 1973; 52:38-46.
41. Solley GO, Gleich GJ, Jordon RE, Schroeter AL. The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest 1976; 58:408-20.
42. Atkins P, Green GR, Zweiman B. Histologic studies of human skin test responses to ragweed, compound 48/80 and histamine. J Allergy Clin Immunol 1973; 51:263-73.
43. James MP, Kennedy AR, Eady RAJ. A microscopic study of inflammatory reactions in human skin induced by histamine and compound 48/80. J Invest Dermatol 1982; 78:406-13.
44. Booij-Noord H, Orie NGM, de Vries K. Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. J Allergy Clin Immunol 1971; 48:344-54.
45. Bradding P. Anti-inflammatory effects of long-acting β-agonists in asthma. Clin Exp Allergy 1995; 25:912-4.
46. Leung DYM, Pober JS, Cotran RS. Expression of endothelial-leucocyte adhesion molecule-1 in elicited late phase allergic reactions. J Clin Invest 1991; 87:1805-9.
47. Schleimer RP, Sterbinsky SA, Kaiser J et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 1992; 148:1086-92.
48. Moser R, Fehr J, Olgiati L, Bruijnzeel PLB. Migration of primed human eosinophils across cytokine-activated endothelial cell monolayers. Blood 1992; 79:2937-45.
49. Wang JM, Rambaldi A, Biondi A et al. Recombinant interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol 1989; 19:701-5.
50. Lopez AF, Sanderson CJ, Gamble JR et al. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988; 167:219-24.
51. Stern M, Meagher L, Savill J, Haslett C. Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 1992; 148:3543-9.
52. Tepper RI, Pattengale PK, Leder P. Murine interleukin 4 displays potent anti-tumour activity in vivo. Cell 1989; 57:503-12.
53. Lukacs NW, Strieter RM, Chensue SW, Kunkel SL. Interleukin 4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am J Respir Cell Mol Biol 1994; 10:526-32.
54. Wenzel SE, Fowler III AA, Schwartz LB. Activation of pulmonary mast cells by bronchoalveolar allergen challenge. Am Rev Respir Dis 1988; 137:1002-8.
55. Henkel G, Weiss DL, McCoy R et al. A DNase I-hypersensitive site in the second intron of the murine IL-4 gene defines a mast-cell specific enhancer. J Immunol 1992; 149:3239-46.
56. Henkel G, Brown MA. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer. Proc Natl Acad Sci USA 1994; 91:7737-41.